A Deep Bayesian Bandits Approach for Anticancer Therapy: Exploration via Functional Prior

• URL: http://arxiv.org/abs/2205.02944v1
• Date: Thu, 5 May 2022 21:56:14 GMT
• Title: A Deep Bayesian Bandits Approach for Anticancer Therapy: Exploration via Functional Prior
• Authors: Mingyu Lu and Yifang Chen and Su-In Lee
• Abstract summary: personalized cancer treatment with machine learning holds great promise to improve cancer patients' chance of survival. Despite recent advances in machine learning and precision oncology, this approach remains challenging. We formulate drug screening study as a "contextual bandit" problem, in which an algorithm selects anticancer therapeutics based on contextual information about cancer cell lines. We propose using a novel deep Bayesian bandits framework that uses functional prior to approximate posterior for drug response prediction based on multi-modal information consisting of genomic features and drug structure.
• Score: 13.368491963797151
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Learning personalized cancer treatment with machine learning holds great promise to improve cancer patients' chance of survival. Despite recent advances in machine learning and precision oncology, this approach remains challenging as collecting data in preclinical/clinical studies for modeling multiple treatment efficacies is often an expensive, time-consuming process. Moreover, the randomization in treatment allocation proves to be suboptimal since some participants/samples are not receiving the most appropriate treatments during the trial. To address this challenge, we formulate drug screening study as a "contextual bandit" problem, in which an algorithm selects anticancer therapeutics based on contextual information about cancer cell lines while adapting its treatment strategy to maximize treatment response in an "online" fashion. We propose using a novel deep Bayesian bandits framework that uses functional prior to approximate posterior for drug response prediction based on multi-modal information consisting of genomic features and drug structure. We empirically evaluate our method on three large-scale in vitro pharmacogenomic datasets and show that our approach outperforms several benchmarks in identifying optimal treatment for a given cell line.

Related papers

• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Towards AI-Based Precision Oncology: A Machine Learning Framework for Personalized Counterfactual Treatment Suggestions based on Multi-Omics Data [0.05025737475817938]
  We propose a modular machine learning framework designed for personalized counterfactual cancer treatment suggestions. The framework is tailored to address critical challenges inherent in data-driven cancer research. Our method aims to empower clinicians with a reality-centric decision-support tool.
  arXiv  Detail & Related papers  (2024-02-19T14:54:20Z)
• Accounting For Informative Sampling When Learning to Forecast Treatment Outcomes Over Time [66.08455276899578]
  We show that informative sampling can prohibit accurate estimation of treatment outcomes if not properly accounted for. We present a general framework for learning treatment outcomes in the presence of informative sampling using inverse intensity-weighting. We propose a novel method, TESAR-CDE, that instantiates this framework using Neural CDEs.
  arXiv  Detail & Related papers  (2023-06-07T08:51:06Z)
• Deep learning methods for drug response prediction in cancer: predominant and emerging trends [50.281853616905416]
  Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans. A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods. This review allows to better understand the current state of the field and identify major challenges and promising solution paths.
  arXiv  Detail & Related papers  (2022-11-18T03:26:31Z)
• Enhancing Clinical Support for Breast Cancer with Deep Learning Models using Synthetic Correlated Diffusion Imaging [66.63200823918429]
  We investigate enhancing clinical support for breast cancer with deep learning models. We leverage a volumetric convolutional neural network to learn deep radiomic features from a pre-treatment cohort. We find that the proposed approach can achieve better performance for both grade and post-treatment response prediction.
  arXiv  Detail & Related papers  (2022-11-10T03:02:12Z)
• RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy [1.8161758803237067]
  We develop a multimodal late fusion approach to predict radiation therapy outcomes for non-small-cell lung cancer patients. Experiments show that the proposed multimodal paradigm with an AUC equal to $90.9%$ outperforms each unimodal approach.
  arXiv  Detail & Related papers  (2022-04-26T16:32:52Z)
• Open-Set Recognition of Breast Cancer Treatments [91.3247063132127]
  Open-set recognition generalizes a classification task by classifying test samples as one of the known classes from training or "unknown" We apply a recent existing Gaussian mixture variational autoencoder model, which achieves state-of-the-art results for image datasets, to breast cancer patient data. Not only do we obtain more accurate and robust classification results, with a 24.5% average F1 increase compared to a recent method, but we also reexamine open-set recognition in terms of deployability to a clinical setting.
  arXiv  Detail & Related papers  (2022-01-09T04:35:55Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)
• Divide-and-Rule: Self-Supervised Learning for Survival Analysis in Colorectal Cancer [9.431791041887957]
  We propose a self-supervised learning method that learns a representation of tissue regions as well as a metric of the clustering to obtain their underlying patterns. We show that the proposed approach can benefit from linear predictors to avoid overfitting in patient outcomes predictions.
  arXiv  Detail & Related papers  (2020-07-07T09:15:36Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.